Octapharma Plasma, Inc.
Octapharma Plasma, Inc., a leading player in the biopharmaceutical industry, is headquartered in the United States and operates numerous plasma donation centres across the country. Founded in 1983, Octapharma has established itself as a key provider of human protein therapies, focusing on the development and production of high-quality plasma-derived products. The company’s core offerings include immunoglobulins, clotting factors, and albumin, which are essential for treating various medical conditions. Octapharma's commitment to innovation and quality has positioned it as a trusted name in the market, with notable achievements in expanding its operational footprint and enhancing patient care. With a strong emphasis on safety and efficacy, Octapharma Plasma continues to play a vital role in the healthcare landscape, making significant contributions to the treatment of patients worldwide.
DitchCarbon Score
How does Octapharma Plasma, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Octapharma Plasma, Inc.'s score of 12 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Octapharma Plasma, Inc.'s reported carbon emissions
Octapharma Plasma, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives. The company has not disclosed any commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As such, there are no specific figures regarding their carbon emissions in kg CO2e or any significant achievements in emissions reduction. In the absence of detailed emissions data, it is important to note that many organisations in the biopharmaceutical sector are increasingly focusing on sustainability and climate commitments. This includes setting reduction targets and implementing initiatives aimed at minimising their carbon footprint. However, without specific information from Octapharma Plasma, Inc., it is unclear how they align with these industry trends.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Octapharma Plasma, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
